Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis

Neuroscience

Volumn 226, Issue , 2012, Pages 282-288

  Russo, E ^a,d   Scicchitano, F ^a   Citraro, R ^a   Aiello, R ^a   Camastra, C ^a   Mainardi, P ^b   Chimirri, S ^a   Perucca, E ^c   Donato, G ^a   De Sarro, G ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d NONE   (Italy)

Author keywords

Absence epilepsy; Antiepileptogenesis; Kynurenic acid; Pilocarpine; Spike wave discharges; WAG Rij rats

Indexed keywords

EID: 84867283591     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.021     Document Type: Article

References (39)

1. Albano C., Cupello A., Mainardi P., Scarrone S., Favale E. Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism. Neurochem Res 2006, 31:509-514.
2. Bagdy G., Kecskemeti V., Riba P., Jakus R. Serotonin and epilepsy. J Neurochem 2007, 100:857-873.
3. Berdichevsky Y., Dzhala V., Mail M., Staley K.J. Interictal spikes, seizures and ictal cell death are not necessary for post-traumatic epileptogenesis in vitro. Neurobiol Dis 2012, 45:774-785.
4. Blumenfeld H., Klein J.P., Schridde U., Vestal M., Rice T., Khera D.S., Bashyal C., Giblin K., Paul-Laughinghouse C., Wang F., Phadke A., Mission J., Agarwal R.K., Englot D.J., Motelow J., Nersesyan H., Waxman S.G., Levin A.R. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 2008, 49:400-409.
5. Borowski T.B., Kirkby R.D., Kokkinidis L. Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures. Brain Res Bull 1993, 30:607-610.
6. Ceyhan M., Kayir H., Uzbay I.T. Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. J Psychiatr Res 2005, 39:191-196.
7. Citraro R., Scicchitano F., De Fazio S., Raggio R., Mainardi P., Perucca E., De Sarro G., Russo E. Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res 2011, 95:60-69.
8. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 2008, 172:143-157.
9. De Grandis E., Serrano M., Pérez-Dueñas B., Ormazábal A., Montero R., Veneselli E., Pineda M., González V., Sanmartí F., Fons C., Sans A., Cormand B., Puelles L., Alonso A., Campistol J., Artuch R., García-Cazorla A. Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders. J Inherit Metab Dis 2010, 33:803-809.
10. De Sarro G., Russo E., Ferreri G., Giuseppe B., Flocco M.A., Di Paola E.D., De Sarro A. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol Biochem Behav 2004, 77:761-766.
11. De Sarro G., Siniscalchi A., Ferreri G., Gallelli L., De Sarro A. NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice. Eur J Pharmacol 2000, 408:25-34.
12. De Sarro G.B., Meldrum B.S., De Sarro A., Patel S. Excitatory neurotransmitters in the lateral habenula and peduncolopontine nucleus of rat modulate limbic seizures induced by pilocarpine. Brain Res 1992, 591:209-222.
13. Du F., Williamson J., Bertram E., Lothman E., Okuno E., Schwarcz R. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells. Neuroscience 1993, 55:975-989.
14. Frasca A., Aalbers M., Frigerio F., Fiordaliso F., Salio M., Gobbi M., Cagnotto A., Gardoni F., Battaglia G.S., Hoogland G., Di Luca M., Vezzani A. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 2011, 43:507-515.
15. Heine W., Radke M., Wutzke K.D., Peters E., Kundt G. Alpha-lactalbumin-enriched low-protein infant formulas: a comparison to breast milk feeding. Acta Paediatr 1996, 85:1024-1028.
16. Jiang X., Mu D., Biran V., Faustino J., Chang S., Rincón C.M., Sheldon R.A., Ferriero D.M. Activated Src kinases interact with the N-methyl-d-aspartate receptor after neonatal brain ischemia. Ann Neurol 2008, 63:632-641.
17. Jones N.C., O'Brien T.J., Powell K.L. Morphometric changes and molecular mechanisms in rat models of idiopathic generalized epilepsy with absence seizures. Neurosci Lett 2011, 497:185-193.
18. Long K.D., Mastropaolo J., Rosse R.B., Manaye K.F., Deutsch S.I. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain. Brain Res Bull 2006, 69:626-630.
19. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002, 50:105-123.
20. Löscher W., Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 2010, 62:668-700.
21. Löscher W., Leppik I.E. Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs. Epilepsy Res 2002, 50:17-20.
22. Markus C.R., Olivier B., Panhuysen G.E., Van Der Gugten J., Alles M.S., Tuiten A., Westenberg H.G., Fekkes D., Koppeschaar H.F., de Haan E.E. The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr 2000, 71:1536-1544.
23. Merlet I., Ostrowsky K., Costes N., Ryvlin P., Isnard J., Faillenot I., Lavenne F., Dufournel D., Le Bars D., Mauguière F. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 2004, 127:900-913.
24. Naffah-Mazzacoratti M.G., Amado D., Cukiert A., Gronich G., Marino R., Calderazzo L., Cavalheiro E.A. Monoamines and their metabolites in cerebrospinal fluid and cortex of epileptic patients. Epilepsy Res 1996, 25:133-137.
25. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd Edition.
26. Russo E., Citraro R., Scicchitano F., De Fazio S., Di Paola E.D., Constanti A., De Sarro G. Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia 2010, 51:1560-1569.
27. Russo E., Citraro R., Scicchitano F., De Fazio S., Perrota I., Donato Di Paola E., Constanti A., De Sarro G. Effects of early long-term treatment with antiepileptic drugs, on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 2011, 52:1341-1350.
28. Russo E., Citraro R., Scicchitano F., Urzino A., Marra R., Rispoli V., De Sarro G. Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav. Brain Res 2011, 225:373-376.
29. Russo E., Constanti A., Ferreri G., Citraro R., De Sarro G. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004, 46:865-878.
30. Russo S., Kema I.P., Bosker F., Haavik J., Korf J. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications. World J Biol Psychiatry 2009, 10:258-268.
31. Sarkisova K., van Luijtelaar G. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:854-876.
32. Schenkel L.C., Bragatti J.A., Torres C.M., Martin K.C., Manfro G.G., Leistner-Segal S., Bianchin M.M. Serotonin transporter gene (5HTT) polymorphisms and temporal lobe epilepsy. Epilepsy Res 2011, 95:152-157.
33. Szyndler J., Maciejak P., Turzyńska D., Sobolewska A., Walkowiak J., Płaźnik A. The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures. J Neural Transm 2012, 119:141-149.
34. Teskey G.C., Radford K.S., Seif I., Dyck R.H. MAO(A) knockout mice are more susceptible to seizures but show reduced epileptogenesis. Epilepsy Res 2004, 59:25-34.
35. Vamos E., Pardutz A., Klivenyi P., Toldi J., Vecsei L. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 2009, 283:21-27.
36. Veliskova J. Behavioral characterization of seizures in rats. Models of seizures and epilepsy 2006, 601-611. Elsevier Academic Press, Burlington. A. Pitkänen, P.A. Schwartskroin, L.M. Solomon (Eds.).
37. Winawer M.R., Makarenko N., McCloskey D.P., Hintz T.M., Nair N., Palmer A.A., Scharfman H.E. Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice. Neuroscience 2007, 149:465-475.
38. Wu H.Q., Monno A., Schwarcz R., Vezzani A. Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus. Neurosci Lett 1995, 198:91-94.
39. Zienowicz M., Wisłowska A., Lehner M., Taracha E., Skórzewska A., Maciejak P., Płaźnik A. The effect of fluoxetine in a model of chemically induced seizures-behavioral and immunocytochemical study. Neurosci Lett 2005, 373:226-231.